Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IL13RA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SRD5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYNC1I2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM20B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR1OP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRLS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP128 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNPNAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKBIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on